Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

Introduction

This page provides a comprehensive analysis of the known insider trading history of Brett A Pletcher. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Brett A Pletcher has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CYTK / Cytokinetics, Incorporated EVP, Chief Legal Officer 33,140
US:GILD / Gilead Sciences, Inc. EVP,Corp Affairs & Gen Counsel 33,426
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Brett A Pletcher. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CYTK / Cytokinetics, Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CYTK / Cytokinetics, Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYTK / Cytokinetics, Incorporated Insider Trades
Insider Sales CYTK / Cytokinetics, Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CYTK / Cytokinetics, Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYTK / Cytokinetics, Incorporated Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Brett A Pletcher as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-09-03 2024-08-30 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 33,140 33,140
2022-06-13 2022-06-10 4 GILD GILEAD SCIENCES, INC.
Common Stock
F - Taxes -280 33,426 -0.83 60.74 -17,007 2,030,295
2022-06-13 2022-06-10 4 GILD GILEAD SCIENCES, INC.
Common Stock
M - Exercise 782 33,706 2.38
2022-04-13 2022-02-15 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 348 32,924 1.07 52.13 18,141 1,716,345
2022-03-14 2022-03-11 4 GILD GILEAD SCIENCES, INC.
Common Stock
S - Sale -3,634 32,576 -10.04 58.24 -211,644 1,897,226
2022-03-14 2022-03-10 4 GILD GILEAD SCIENCES, INC.
Restricted Stock Unit
M - Exercise -3,130 17,301 -15.32
2022-03-14 2022-03-10 4 GILD GILEAD SCIENCES, INC.
Restricted Stock Unit
M - Exercise -2,593 20,431 -11.26
2022-03-14 2022-03-10 4 GILD GILEAD SCIENCES, INC.
Common Stock
F - Taxes -2,089 36,210 -5.45 57.92 -120,995 2,097,283
2022-03-14 2022-03-10 4 GILD GILEAD SCIENCES, INC.
Common Stock
M - Exercise 3,130 38,299 8.90
2022-03-14 2022-03-10 4 GILD GILEAD SCIENCES, INC.
Common Stock
M - Exercise 2,593 35,169 7.96
2022-02-11 2022-02-09 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -1,691 32,576 -4.93 63.89 -108,038 2,081,281
2022-02-08 2022-02-06 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -2,727 23,024 -10.59
2022-02-08 2022-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -1,036 34,267 -2.93 63.90 -66,200 2,189,661
2022-02-08 2022-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 2,727 35,303 8.37
2022-02-02 2022-02-01 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -14,061 32,576 -30.15 68.54 -963,682 2,232,622
2022-01-28 2022-01-26 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -5,681 46,637 -10.86 67.34 -382,559 3,140,536
2022-01-28 2022-01-26 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 19,742 52,318 60.60
2022-01-28 2022-01-26 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 15,262 32,576 88.15
2021-08-24 2021-08-15 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 32 29,198 0.11 55.08 1,763 1,608,226
2021-03-12 2021-03-11 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -1,486 29,166 -4.85 63.36 -94,153 1,847,958
2021-03-12 2021-03-10 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
A - Award 72,855 72,855
2021-03-12 2021-03-10 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
A - Award 12,520 25,751 94.63
2021-03-12 2021-03-10 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -2,593 13,231 -16.39
2021-03-12 2021-03-10 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -1,107 30,652 -3.49 63.91 -70,748 1,958,969
2021-03-12 2021-03-10 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 2,593 31,759 8.89
2021-03-12 2021-02-15 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 334 29,166 1.16 56.86 18,990 1,658,277
2021-02-11 2021-02-10 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -1,975 28,832 -6.41 67.41 -133,135 1,943,565
2021-02-09 2021-02-06 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -2,728 15,824 -14.70
2021-02-09 2021-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -753 30,807 -2.39 68.46 -51,550 2,109,047
2021-02-09 2021-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 2,728 31,560 9.46
2021-02-03 2021-02-01 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -9,711 28,832 -25.20 65.97 -640,633 1,902,041
2021-01-28 2021-01-26 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -3,736 38,543 -8.84 66.70 -249,191 2,570,818
2021-01-28 2021-01-26 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 13,447 42,279 46.64
2021-01-28 2021-01-26 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 14,188 28,832 96.89
2020-05-07 2020-05-05 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -650 0 -100.00
2020-05-07 2020-05-05 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -12,560 0 -100.00
2020-05-07 2020-05-05 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -13,210 14,644 -47.43 79.23 -1,046,640 1,160,257
2020-05-07 2020-05-05 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 650 27,854 2.39 24.30 15,792 676,713
2020-05-07 2020-05-05 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 12,560 27,204 85.77 40.56 509,434 1,103,394
2020-03-12 2020-03-10 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
A - Award 10,370 18,552 126.74
2020-03-12 2020-03-10 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
A - Award 61,590 61,590
2020-03-12 2020-03-10 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise X -2,950 650 -81.94
2020-03-12 2020-03-10 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -2,950 14,644 -16.77 75.55 -222,872 1,106,354
2020-03-12 2020-03-10 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise X 2,950 17,594 20.14 24.30 71,670 427,446
2020-03-03 2020-03-02 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -1,100 14,644 -6.99 71.26 -78,383 1,043,492
2020-03-03 2020-03-02 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -9,341 15,744 -37.24 70.83 -661,631 1,115,160
2020-03-03 2020-02-15 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 395 25,085 1.60 53.67 21,199 1,346,287
2020-02-12 2020-02-10 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise X -2,950 3,600 -45.04
2020-02-12 2020-02-10 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -2,950 24,690 -10.67 69.32 -204,494 1,711,511
2020-02-12 2020-02-10 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise X 2,950 27,640 11.95 24.30 71,670 671,514
2020-02-10 2020-02-07 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -1,426 24,690 -5.46 70.00 -99,820 1,728,300
2020-02-10 2020-02-06 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -2,728 8,182 -25.00
2020-02-10 2020-02-06 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -5,000 12,560 -28.47
2020-02-10 2020-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -1,302 26,116 -4.75 68.21 -88,809 1,781,372
2020-02-10 2020-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 2,728 27,418 11.05
2020-02-10 2020-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -5,000 24,690 -16.84 68.18 -340,900 1,683,367
2020-02-10 2020-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 5,000 29,690 20.25 40.56 202,800 1,204,226
2020-01-31 2020-01-29 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -4,587 24,690 -15.67 64.30 -294,944 1,587,567
2020-01-31 2020-01-29 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 4,126 29,277 16.40
2020-01-31 2020-01-29 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 8,087 25,151 47.39
2020-01-06 2020-01-03 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise X -2,950 6,550 -31.05
2020-01-06 2020-01-03 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -2,950 17,064 -14.74 64.63 -190,658 1,102,846
2020-01-06 2020-01-03 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise X 2,950 20,014 17.29 24.30 71,670 486,240
2019-12-04 2019-12-03 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise X -5,900 9,500 -38.31
2019-12-04 2019-12-03 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -5,900 17,064 -25.69 65.77 -388,043 1,122,299
2019-12-04 2019-12-03 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise X 5,900 22,964 34.58 24.30 143,340 557,910
2019-11-26 2019-11-25 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -15,000 17,560 -46.07
2019-11-26 2019-11-25 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -15,000 17,064 -46.78 66.85 -1,002,808 1,140,795
2019-11-26 2019-11-25 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 15,000 32,064 87.90 40.56 608,400 1,300,516
2019-11-20 2019-11-19 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -10,000 15,400 -39.37
2019-11-20 2019-11-19 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -10,000 17,064 -36.95 64.91 -649,062 1,107,559
2019-11-20 2019-11-19 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 10,000 27,064 58.60 24.30 242,950 657,520
2019-11-20 2019-11-18 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -10,000 25,400 -28.25
2019-11-20 2019-11-18 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -10,000 17,064 -36.95 63.85 -638,500 1,089,536
2019-11-20 2019-11-18 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 10,000 27,064 58.60 24.30 242,950 657,520
2019-11-20 2019-11-14 4 GILD GILEAD SCIENCES INC
Common Stock
G - Gift -762 17,064 -4.27
2019-11-07 2019-11-05 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -2,095 17,826 -10.52 66.06 -138,404 1,177,653
2019-11-05 2019-11-01 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise -2,400 0 -100.00
2019-11-05 2019-11-01 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -4,000 19,921 -16.72 64.52 -258,099 1,285,397
2019-11-05 2019-11-01 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 2,400 23,921 11.15 16.89 40,536 404,026
2019-10-30 2019-10-28 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -5,677 21,521 -20.87 63.31 -359,412 1,362,499
2019-08-20 2019-08-19 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -608 27,198 -2.19 64.35 -39,123 1,750,131
2019-08-13 2019-08-10 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -1,070 10,910 -8.93
2019-08-13 2019-08-10 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -462 27,806 -1.63 65.24 -30,141 1,814,063
2019-08-13 2019-08-10 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 1,070 28,268 3.93
2019-07-25 2019-07-23 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
M - Exercise X -7,200 0 -100.00
2019-07-25 2019-07-23 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale -7,200 27,198 -20.93 65.07 -468,504 1,769,774
2019-07-25 2019-07-23 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise X 7,200 34,398 26.47 24.90 179,316 856,682
2019-06-20 2019-06-18 4 GILD GILEAD SCIENCES INC
Common Stock
S - Sale X -5,816 27,198 -17.62 68.75 -399,850 1,869,862
2019-03-14 2019-02-15 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 330 33,014 1.01 57.45 18,959 1,896,704
2019-02-08 2019-02-06 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
A - Award 10,910 11,980 1,019.63
2019-02-08 2019-02-06 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
A - Award 50,480 50,480
2019-02-08 2019-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -3,871 32,684 -10.59 68.75 -266,131 2,247,025
2019-02-08 2019-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 6,463 36,555 21.48
2019-02-08 2019-02-06 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 9,386 30,092 45.33
2018-09-19 2018-08-15 4 GILD GILEAD SCIENCES INC
Common Stock
A - Award 94 20,706 0.46 63.61 5,980 1,317,191
2018-08-14 2018-08-10 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -1,070 1,070 -50.00
2018-08-14 2018-08-10 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -489 20,612 -2.32 76.73 -37,521 1,581,559
2018-08-14 2018-08-10 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 1,070 21,101 5.34
2018-08-02 2018-07-31 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -2,000 2,140 -48.31
2018-08-02 2018-07-31 4 GILD GILEAD SCIENCES INC
Common Stock
F - Taxes -910 20,031 -4.35 77.83 -70,825 1,559,013
2018-08-02 2018-07-31 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 2,000 20,941 10.56
2018-05-16 3 GILD GILEAD SCIENCES INC
Common Stock
37,882
2018-05-16 3 GILD GILEAD SCIENCES INC
Common Stock
37,882
2018-05-16 3 GILD GILEAD SCIENCES INC
Common Stock
37,882
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)